Pathstone Holdings LLC Grows Position in Omega Healthcare Investors, Inc. (NYSE:OHI)

Pathstone Holdings LLC grew its stake in Omega Healthcare Investors, Inc. (NYSE:OHI) by 23.9% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 32,112 shares of the real estate investment trust’s stock after buying an additional 6,199 shares during the quarter. Pathstone Holdings LLC’s holdings in Omega Healthcare Investors were worth $1,307,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Quest Partners LLC bought a new stake in Omega Healthcare Investors during the third quarter valued at about $514,000. Thrivent Financial for Lutherans raised its stake in Omega Healthcare Investors by 1.5% during the 3rd quarter. Thrivent Financial for Lutherans now owns 60,575 shares of the real estate investment trust’s stock valued at $2,465,000 after purchasing an additional 871 shares during the period. GoalVest Advisory LLC lifted its holdings in Omega Healthcare Investors by 3.0% in the 3rd quarter. GoalVest Advisory LLC now owns 34,214 shares of the real estate investment trust’s stock worth $1,393,000 after purchasing an additional 993 shares in the last quarter. Natixis Advisors LLC boosted its stake in Omega Healthcare Investors by 1.1% in the 3rd quarter. Natixis Advisors LLC now owns 31,711 shares of the real estate investment trust’s stock worth $1,291,000 after purchasing an additional 331 shares during the period. Finally, Euro Pacific Asset Management LLC purchased a new stake in Omega Healthcare Investors during the 3rd quarter valued at approximately $236,000. Institutional investors own 65.25% of the company’s stock.

Wall Street Analysts Forecast Growth

OHI has been the topic of several research analyst reports. Scotiabank upped their target price on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “sector perform” rating in a research report on Monday, August 26th. Berenberg Bank began coverage on Omega Healthcare Investors in a research report on Friday, October 18th. They set a “buy” rating and a $45.00 price objective for the company. Royal Bank of Canada boosted their target price on Omega Healthcare Investors from $39.00 to $43.00 and gave the stock a “sector perform” rating in a research report on Monday, November 11th. BMO Capital Markets raised their price target on Omega Healthcare Investors from $44.00 to $45.00 and gave the company a “market perform” rating in a report on Monday, October 7th. Finally, Truist Financial upped their price objective on Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “hold” rating in a report on Wednesday, September 4th. Seven research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat, Omega Healthcare Investors presently has an average rating of “Hold” and a consensus price target of $40.00.

Insider Activity

In other news, CFO Robert O. Stephenson sold 22,542 shares of the business’s stock in a transaction on Friday, September 27th. The shares were sold at an average price of $40.19, for a total transaction of $905,962.98. Following the completion of the sale, the chief financial officer now directly owns 183,076 shares of the company’s stock, valued at approximately $7,357,824.44. The trade was a 10.96 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, COO Daniel J. Booth sold 56,725 shares of the firm’s stock in a transaction dated Friday, September 27th. The stock was sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the completion of the transaction, the chief operating officer now directly owns 100,000 shares in the company, valued at $4,025,000. This represents a 36.19 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.37% of the company’s stock.

Omega Healthcare Investors Trading Down 0.2 %

Shares of OHI opened at $40.67 on Friday. The company’s fifty day simple moving average is $40.61 and its 200-day simple moving average is $37.24. The company has a market cap of $10.98 billion, a P/E ratio of 29.90, a P/E/G ratio of 1.25 and a beta of 0.99. The company has a current ratio of 6.48, a quick ratio of 6.48 and a debt-to-equity ratio of 1.10. Omega Healthcare Investors, Inc. has a twelve month low of $27.53 and a twelve month high of $44.42.

Omega Healthcare Investors Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Monday, November 4th were given a dividend of $0.67 per share. The ex-dividend date of this dividend was Monday, November 4th. This represents a $2.68 annualized dividend and a dividend yield of 6.59%. Omega Healthcare Investors’s dividend payout ratio (DPR) is presently 197.06%.

Omega Healthcare Investors Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.